Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.
Where this comes from
- Record sourced from PubMed, PMID 35653357.
- Also identified by DOI 10.1371/journal.pone.0269623 and PMC identifier 9162307.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0263252.].